Pharmathen - Ownership and Business Overview

Life ScienceCompany

Pharmathen Ownership

Who owns Pharmathen?

Pharmathen is owned by CVC Capital Partners and Partners Group AG. It was acquired on July 19, 2021.

Is Pharmathen PE-backed?

Yes. Pharmathen is owned by private equity investors CVC Capital Partners and Partners Group AG.

Was Pharmathen formerly PE-backed?

Yes. Pharmathen was formerly owned by 1 private investor.

Pharmathen Business Overview

Where is Pharmathen headquartered?

Pharmathen is headquartered in Amstelveen, Netherlands.

How many employees does Pharmathen have?

Pharmathen has 1,000 employees.

What sector is Pharmathen in?

Pharmathen is a life science company.

When was Pharmathen founded?

Pharmathen was founded in 1969.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 391 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 345 by strategics.

Pharmathen

Pharmathen Global BV

9, Van Heuven Goedhartlaan,
Amstelveen, 1181 LE
Netherlands,
+31 (0) 20 799 5085
www.pharmathen.com

Pharmathen is a European pharmaceutical company that focuses on developing, manufacturing, and out-licensing complex generic pharmaceutical products. Pharmathen's differentiated B2B model attracts a blue-chip customer base of more than 215 generic pharmaceutical companies, which it serves from two US/EU-approved manufacturing facilities in Greece. Pharmathen was founded in 1969 and is based in Amstelveen, Netherlands.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Pharmathen

Life Science Companies , Netherlands Companies